We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Relay Therapeutics
RLAY
$4.4B
| $71.3K | ﹤0.01% |
8,422
+1,757
| +26% | +$12.5K |
|
1327
Collegium Pharmaceutical
COLL
$834M
| $71.1K | ﹤0.01% |
1,536
+318
| +26% | +$13.3K |
|
1328
Urban Edge Properties
UE
$2.75B
| $70.6K | ﹤0.01% |
3,677
+922
| +33% | +$17.9K |
|
1329
Four Corners Property Trust
FCPT
$2.74B
| $70.4K | ﹤0.01% |
3,054
+853
| +39% | +$20.3K |
|
1330
Sasol
SSL
$7.36B
| $70.4K | ﹤0.01% |
10,813
-9,919
| -48% | -$62.7K |
|
1331
NovoCure
NVCR
$2.05B
| $70.4K | ﹤0.01% |
5,442
+1,120
| +26% | +$14.4K |
|
|
RAPP
1332
Rapport Therapeutics
RAPP
$2.29B
| $70.3K | ﹤0.01% |
2,316
+905
| +64% | +$25K |
|
|
LINE
1333
Lineage Inc
LINE
$9.45B
| $70.2K | ﹤0.01% |
2,005
+502
| +33% | +$18.6K |
|
1334
Copa Holdings
CPA
$6.14B
| $69.4K | ﹤0.01% |
575
-175
| -23% | -$21.4K |
|
1335
Grupo Aeroportuario Centro Norte
OMAB
$5.28B
| $69.2K | ﹤0.01% |
636
-329
| -34% | -$34.4K |
|
1336
Ardelyx
ARDX
$1.03B
| $68.8K | ﹤0.01% |
11,807
+2,491
| +27% | +$13.9K |
|
|
MBX
1337
MBX Biosciences
MBX
$3.23B
| $68.8K | ﹤0.01% |
+2,182
| New | +$52.9K |
|
1338
Tyra Biosciences
TYRA
$1.51B
| $68.2K | ﹤0.01% |
2,594
+534
| +26% | +$9.81K |
|
|
AAPG
1339
Ascentage Pharma
AAPG
$1.77B
| $66.8K | ﹤0.01% |
2,546
+83
| +3% | +$2.72K |
|
1340
Vista Energy
VIST
$7.31B
| $65.3K | ﹤0.01% |
1,342
+67
| +5% | +$3.03K |
|
|
YALA
1341
Yalla Group
YALA
$821M
| $65.3K | ﹤0.01% |
9,403
| – | – |
|
1342
AnaptysBio
ANAB
$1.69B
| $65.2K | ﹤0.01% |
1,345
+263
| +24% | +$10.3K |
|
1343
Amylyx Pharmaceuticals
AMLX
$2.6B
| $64.5K | ﹤0.01% |
5,337
+1,890
| +55% | +$25.7K |
|
|
CURB
1344
Curbline Properties
CURB
$3.46B
| $64.2K | ﹤0.01% |
2,768
+694
| +33% | +$16.2K |
|
1345
InvenTrust Properties
IVT
$2.59B
| $64K | ﹤0.01% |
2,269
+570
| +34% | +$16.1K |
|
1346
MINISO
MNSO
$3.55B
| $63.7K | ﹤0.01% |
3,397
+16
| +0.5% | +$332 |
|
1347
Chord Energy
CHRD
$7.53B
| $63.3K | ﹤0.01% |
683
-139
| -17% | -$12.9K |
|
1348
Xeris Biopharma Holdings
XERS
$1.55B
| $63.3K | ﹤0.01% |
8,063
+1,820
| +29% | +$14.3K |
|
1349
Snap
SNAP
$8.79B
| $62.3K | ﹤0.01% |
7,720
+3,424
| +80% | +$27.1K |
|
|
ECHO
1350
EchoStar
ECHO
$26.9B
| $62.2K | ﹤0.01% |
+572
| New | +$46.6K |
|
Similar funds
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.